Haddose Pharmaceuticals Private Limited

Founded in 2015 and headquartered in Kerala, India.

2015 | Kozhikode, Kerala (India) | Inactive
Last Updated: April 18, 2024

Haddose Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 8 Months

About Haddose Pharmaceuticals

Haddose Pharmaceuticals Private Limited (HPPL) is Strike Off company established on 19 May 2015 with its office registered at Kozhikode, Kerala, India and has been running since 9 Year, 8 Months with a paid up capital of 0.10 M. According to MCA records, 4 Directors are linked to this company as of 18 Apr 2024.

Company Details

  • Location

    Kozhikode, Kerala, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230KL2015PTC038499

  • Company No.

    038499

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    19 May 2015

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ernakulam

Industry

Chemicals
Pharmaceuticals

Who are the key members and board of directors at Haddose Pharmaceuticals?

Board Members (4)

Name Designation Appointment Date Status
Mundani Haridas Country flag representing In Director 19-May-2015 Current
Riyaz Rafique Country flag representing In Director 19-May-2015 Current
Hafis Punathilparamda Country flag representing In Director 19-May-2015 Current
Shaji Koorkkapparamba Country flag representing In Director 19-May-2015 Current

Financial Performance of Haddose Pharmaceuticals.

Enhance accessibility to Haddose Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Haddose Pharmaceuticals?

Unlock access to Haddose Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Haddose Pharmaceuticals?

Unlock and access historical data on people associated with Haddose Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Haddose Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haddose Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Haddose Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Mundani Suhanesh Haridas was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 9 years 8 months .

    19 May 2015

  • Director Appointment

    Riyaz Mohammed Rafique was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 9 years 8 months .

    19 May 2015

  • Director Appointment

    Hafis Punathilparamda was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 9 years 8 months .

    19 May 2015

  • Director Appointment

    Shaji Koorkkapparamba was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 9 years 8 months .

    19 May 2015

  • Company Incorporation

    Haddose Pharmaceuticals Private Limited was registered on 19 May 2015 with Roc Ernakulam & aged 9 years 8 months as per MCA records.

    19 May 2015

Frequently asked questions

  • Haddose Pharmaceuticals Private Limited was incorporated on 19 May 2015.

  • The authorized share capital of Haddose Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 4 directors are associated with Haddose Pharmaceuticals Private Limited.

    • Mundani Suhanesh Haridas
    • Riyaz Mohammed Rafique
    • Hafis Punathilparamda
    • Shaji Koorkkapparamba
  • As per Ministry of Corporate Affairs (Mca), the registered address of Haddose Pharmaceuticals Private Limited is Op 8/772 L Kunnathupalam, Olavanna Po, Calicut Kozhikode, Kerala, India, 673014.

  • The corporate identification number (CIN) of Haddose Pharmaceuticals Private Limited is U24230KL2015PTC038499 and the company number is 038499 as per Ministry of Corporate Affairs (MCA).